Clinical trials
2 active studies led by Nalu Medical, Inc., of 3 in all
Source: ClinicalTrials.gov, Studies with Nalu Medical, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 2Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Nalu Medical, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Nalu Medical, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
US device clearances
1 510(k) clearances and PMA approvals since 2015
- Ipg, Integrated, 25/40 Cm, Single, Tined, Ipg, 2 Cm, Single 4, Lead (25/40 Cm, … K191435 · 6 Sep 2019
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Trials over time
Studies Nalu Medical, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Nalu Medical, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Nalu Medical, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Healthcare Topics
The topics of the markets Nalu Medical, Inc. is in.
From our blog
Stories on the topics Nalu Medical, Inc. works in.
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Alzheimer's Diagnosis: Blood Tests and Earlier Answers
57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help…
Read
Cannabis-Based Medicines: Science and Regulation
The FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Read